{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:46:59Z","timestamp":1753894019654,"version":"3.41.2"},"reference-count":48,"publisher":"Pensoft Publishers","issue":"3","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p><jats:bold>Aim<\/jats:bold>: To investigate the value of the hematological indices to differentiate bacterial vaginosis (BV) from vulvovaginal candidiasis (VVC) and predict treatment response.<\/jats:p>\n          <jats:p><jats:bold>Materials and methods<\/jats:bold>: This nested case-control study included 390 women divided into three groups: healthy women, women diagnosed with BV, and women diagnosed with VVC. Additionally, two groups (BV and VVC) were treated and followed prospectively until cured. Demographic data, blood indices, and high-sensitivity C-reactive protein (hsCRP) were obtained from the women.<\/jats:p>\n          <jats:p><jats:bold>Results<\/jats:bold>: hsCRP and neutrophil-lymphocyte ratio (NLR) showed the best diagnostic utility to predict BV with AUC=0.721 and 0.735, respectively. hsCRP showed the best specificity (99.23%), while NLR showed the best sensitivity (82.31%) to differentiate BV. Regarding percentage change after treatment, NLR showed a higher reduction percentage in the BV group (\u221227.41\u00b18.151%) than VVC (0.158\u00b15.804%).<\/jats:p>\n          <jats:p><jats:bold>Conclusions<\/jats:bold>: NLR is an efficient diagnostic instrument for distinguishing individuals with bacterial vaginosis from those with vulvovaginal candidiasis. Its diagnostic reliability is comparable to more regularly used markers such as WBC and hsCRP. Both NLR and PLR are good predictors of clinical response to treatment in bacterial vaginosis.<\/jats:p>","DOI":"10.3897\/folmed.67.e146769","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:29:07Z","timestamp":1748870947000},"source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with vaginitis: nested case-control study"],"prefix":"10.3897","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5185-1049","authenticated-orcid":true,"given":"Ali Mohammed Ali","family":"Al-Nuaimi","sequence":"first","affiliation":[{"name":"\u200eGilgamesh University, Baghdad, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"146769_B1","doi-asserted-by":"crossref","unstructured":"1. Committee on Practice Bulletins - Gynecology. Vaginitis in nonpregnant patients: ACOG Practice Bulletin, number 215. Obstet Gynecol 2020; 135(1):e1\u201317.","DOI":"10.1097\/AOG.0000000000003604"},{"key":"146769_B2","doi-asserted-by":"crossref","unstructured":"2. Peebles K, Velloza J, Balkus JE, et al. High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sex Transm Dis 2019; 46(5):304\u201311.","DOI":"10.1097\/OLQ.0000000000000972"},{"key":"146769_B3","doi-asserted-by":"crossref","unstructured":"3. Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Reports 2021; 70(4):1\u2013187.","DOI":"10.15585\/mmwr.rr7004a1"},{"key":"146769_B4","doi-asserted-by":"crossref","unstructured":"4. Koumans EH, Sternberg M, Bruce C, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis 2007; 34(11):864\u20139.","DOI":"10.1097\/OLQ.0b013e318074e565"},{"key":"146769_B5","doi-asserted-by":"crossref","unstructured":"5. Neal CM, Kus LH, Eckert LO, et al. Noncandidal vaginitis: a comprehensive approach to diagnosis and management. Am J Obstetr Gynecol 2020; 222(2):114\u201322.","DOI":"10.1016\/j.ajog.2019.09.001"},{"key":"146769_B6","doi-asserted-by":"crossref","unstructured":"6. Money D. The laboratory diagnosis of bacterial vaginosis. Can J Infect Dis Med Microbiol 2005; 16(2):77\u20139.","DOI":"10.1155\/2005\/230319"},{"key":"146769_B7","doi-asserted-by":"crossref","unstructured":"7. Abou Chacra L, Fenollar F, Diop K. Bacterial vaginosis: what do we currently know? Front Cell Infect Microbiol 2021; 11:672429.","DOI":"10.3389\/fcimb.2021.672429"},{"key":"146769_B8","doi-asserted-by":"crossref","unstructured":"8. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009; 1(6):a001651.","DOI":"10.1101\/cshperspect.a001651"},{"key":"146769_B9","doi-asserted-by":"crossref","unstructured":"9. Al-Nuaimi AMA, Al-Nuaimi ZMA. Early hematological indices as a predictor of placenta accreta in women with high suspicion of accreta. Medicine (United States) 2025; 104(1):e41084.","DOI":"10.1097\/MD.0000000000041084"},{"key":"146769_B10","doi-asserted-by":"crossref","unstructured":"10. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 2007; 65(12 Pt 2):S140\u20136.","DOI":"10.1301\/nr.2007.dec.S140-S146"},{"key":"146769_B11","doi-asserted-by":"crossref","unstructured":"11. Al-Nuaimi AMA. Role of hematological indices in predicting preeclampsia and its severity: retrospective case-control study. Medicine (United States) 2024;103(25):e38557.","DOI":"10.1097\/MD.0000000000038557"},{"key":"146769_B12","doi-asserted-by":"crossref","unstructured":"12. Mourad AM, Abdulla Z, Abbas MT, et al. Role of matrix metalloproteinase-9 in the pathogenesis of preeclampsia. Int J Women\u2019s Health Reprod Sci 2023; 11(3):116\u201320.","DOI":"10.15296\/ijwhr.2023.20"},{"key":"146769_B13","doi-asserted-by":"crossref","unstructured":"13. Numan AT, Jawad NK, Fawzi HA. Biochemical study of the risk of diabetes, prediabetic and insulin resistance in car painters and its association with mercury exposure: A retrospective case-control study. Toxicol Res 2024; 13(6):tfae221.","DOI":"10.1093\/toxres\/tfae221"},{"key":"146769_B14","doi-asserted-by":"crossref","unstructured":"14. Ibrahim WW, Kadhim EJ, Abbas NS, et al. Serological markers of autoimmunity in women with polycystic ovary syndrome. Int J Res Pharmaceut Sci 2019; 10(3):1746\u201350.","DOI":"10.26452\/ijrps.v10i3.1366"},{"key":"146769_B15","doi-asserted-by":"crossref","unstructured":"15. Chen L, Deng H, Cui H, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 2018; 9(6):7204\u201318.","DOI":"10.18632\/oncotarget.23208"},{"key":"146769_B16","doi-asserted-by":"crossref","unstructured":"16. Al-Naimi MS, Abu-Raghif AR, Fawzi HA. Novel therapeutic effects of rifaximin in combination with methylprednisolone for LPS-induced oxidative stress and inflammation in mice: An in vivo study. Toxicol Rep 2024; 13:101808.","DOI":"10.1016\/j.toxrep.2024.101808"},{"key":"146769_B17","doi-asserted-by":"crossref","unstructured":"17. Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108(19):2317\u201322.","DOI":"10.1161\/01.CIR.0000097109.90783.FC"},{"key":"146769_B18","doi-asserted-by":"crossref","unstructured":"18. Bautista LE, Vera LM, Arenas IA, et al. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-alpha) and essential hypertension. J Hum Hypertens 2005; 19(2):149\u201354.","DOI":"10.1038\/sj.jhh.1001785"},{"key":"146769_B19","doi-asserted-by":"crossref","unstructured":"19. Machowska A, Carrero JJ, Lindholm B, et al. Therapeutics targeting persistent inflammation in chronic kidney disease. Transl Res 2016; 167(1):204\u201313.","DOI":"10.1016\/j.trsl.2015.06.012"},{"key":"146769_B20","doi-asserted-by":"crossref","unstructured":"20. Carrero JJ, Yilmaz MI, Lindholm B, et al. Cytokine dysregulation in chronic kidney disease: how can we treat it? Blood Purif 2008; 26(3):291\u20139.","DOI":"10.1159\/000126926"},{"key":"146769_B21","doi-asserted-by":"crossref","unstructured":"21. Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Investig Dermatol 2007; 127(5):1009\u201317.","DOI":"10.1038\/sj.jid.5700811"},{"key":"146769_B22","doi-asserted-by":"crossref","unstructured":"22. Robb CT, Regan KH, Dorward DA, et al. Key mechanisms governing resolution of lung inflammation. Semin Immunopathol 2016; 38(4):425\u201348.","DOI":"10.1007\/s00281-016-0560-6"},{"key":"146769_B23","doi-asserted-by":"crossref","unstructured":"23. Jabbour HN, Sales KJ, Catalano RD, et al. Inflammatory pathways in female reproductive health and disease. Reproduction 2009; 138(6):903\u201319.","DOI":"10.1530\/REP-09-0247"},{"key":"146769_B24","doi-asserted-by":"crossref","unstructured":"24. Aggrey AA, Srivastava K, Ture S, et al. Platelet induction of the acute-phase response is protective in murine experimental cerebral malaria. J Immunol (Baltimore, Md: 1950) 2013; 190(9):4685\u201391.","DOI":"10.4049\/jimmunol.1202672"},{"key":"146769_B25","doi-asserted-by":"crossref","unstructured":"25. Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy 2021; 122(7):474\u201388.","DOI":"10.4149\/BLL_2021_078"},{"key":"146769_B26","doi-asserted-by":"crossref","unstructured":"26. Wu H, Cao T, Ji T, et al. Predictive value of the neutrophil-to-lymphocyte ratio in the prognosis and risk of death for adult sepsis patients: a meta-analysis. Front Immunol 2024;15:1336456.","DOI":"10.3389\/fimmu.2024.1336456"},{"key":"146769_B27","doi-asserted-by":"crossref","unstructured":"27. Wen X, Zhang Y, Xu J, et al. The early predictive roles of NLR and NE% in in-hospital mortality of septic patients. Heliyon 2024; 10(4):e26563.","DOI":"10.1016\/j.heliyon.2024.e26563"},{"key":"146769_B28","doi-asserted-by":"crossref","unstructured":"28. Buonacera A, Stancanelli B, Colaci M, et al. Neutrophil-to- lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci 2022; 23(7):3636.","DOI":"10.3390\/ijms23073636"},{"key":"146769_B29","doi-asserted-by":"crossref","unstructured":"29. Gasparyan AY, Ayvazyan L, Mukanova U, et al. The platelet-to-lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med 2019; 39(4):345\u201357.","DOI":"10.3343\/alm.2019.39.4.345"},{"key":"146769_B30","unstructured":"30. Mohammed AH, Numan NAM, Al-Temimi GF, et al. A comparative study among effects of treatment with nifedipine, verapamil, diazepam or alpha-methyldopa on platelets count and behavior in women with preeclampsia. Int J Res Pharmaceut Sci 2019; 10(1):444\u201352."},{"key":"146769_B31","doi-asserted-by":"crossref","unstructured":"31. Buggio L, Somigliana E, Borghi A, et al. Probiotics and vaginal microecology: fact or fancy? BMC Womens Health 2019; 19(1):25.","DOI":"10.1186\/s12905-019-0723-4"},{"key":"146769_B32","doi-asserted-by":"crossref","unstructured":"32. Amsel R, Totten PA, Spiegel CA, et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74(1):14\u201322.","DOI":"10.1016\/0002-9343(83)91112-9"},{"key":"146769_B33","doi-asserted-by":"crossref","unstructured":"33. Wilkins J, Gallimore JR, Moore EG, et al. Rapid automated high sensitivity enzyme immunoassay of C-reactive protein. Clin Chem 1998; 44(6 Pt 1):1358\u201361.","DOI":"10.1093\/clinchem\/44.6.1358"},{"key":"146769_B34","doi-asserted-by":"crossref","unstructured":"34. Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39(2):175\u201391.","DOI":"10.3758\/BF03193146"},{"key":"146769_B35","doi-asserted-by":"crossref","unstructured":"35. Faul F, Erdfelder E, Buchner A, et al. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 2009; 41(4):1149\u201360.","DOI":"10.3758\/BRM.41.4.1149"},{"key":"146769_B36","doi-asserted-by":"crossref","unstructured":"36. Khafaji AW, Al-Zubaidy AA, Farhood IG, et al. Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 2025; 398(2):1545\u201356.","DOI":"10.1007\/s00210-024-03359-2"},{"key":"146769_B37","doi-asserted-by":"crossref","unstructured":"37. Karvane HB, Esfandiari H, Qutaiba O, et al. Metabolic syndrome in association with novel dietary index, metabne HB, Esfandiari H, Qutaiba O, et al. Metabolic syndrome in association with novel dietary index, metabolic parameters, nesfatin-1 and omentin-1. BMC Endocrine Disorders 2024; 24(1):257.","DOI":"10.1186\/s12902-024-01791-2"},{"key":"146769_B38","doi-asserted-by":"crossref","unstructured":"38. Khudair FA, Ali SH, Al-Nuaimi AAM. Study of association between RAGE gene polymorphism rs2070600 (G82S) and aspirin resistance in coronary artery disease Iraqi Patients with and without type 2 diabetes. J Pharm Negat Results 2022; 13(4):170\u201382.","DOI":"10.47750\/pnr.2022.13.04.022"},{"key":"146769_B39","doi-asserted-by":"crossref","unstructured":"39. Modak T, Arora P, Agnes C, et al. Diagnosis of bacterial vaginosis in cases of abnormal vaginal discharge: comparison of clinical and microbiological criteria. J Infect Developing Countries 2011; 5(5):353\u201360.","DOI":"10.3855\/jidc.1153"},{"key":"146769_B40","doi-asserted-by":"crossref","unstructured":"40. Klebanoff MA, Schwebke JR, Zhang J, et al. Vulvovaginal symptoms in women with bacterial vaginosis. Obst and Gynae 2004; 104(2):267\u201372.","DOI":"10.1097\/01.AOG.0000134783.98382.b0"},{"key":"146769_B41","doi-asserted-by":"crossref","unstructured":"41. Redelinghuys MJ, Geldenhuys J, Jung H, et al. Bacterial vaginosis: current diagnostic avenues and future opportunities. Front Cell Infect Microbiol 2020; 10:354.","DOI":"10.3389\/fcimb.2020.00354"},{"key":"146769_B42","doi-asserted-by":"crossref","unstructured":"42. Song M, Graubard BI, Rabkin CS, et al. Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci Rep 2021; 11(1):464.","DOI":"10.1038\/s41598-020-79431-7"},{"key":"146769_B43","unstructured":"43. Zahorec R. Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102(1):5\u201314."},{"key":"146769_B44","doi-asserted-by":"crossref","unstructured":"44. De Jager CP, van Wijk PT, Mathoera RB, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Critical Care (London, England) 2010; 14(5):R192.","DOI":"10.1186\/cc9309"},{"key":"146769_B45","doi-asserted-by":"crossref","unstructured":"45. Holub M, Beran O, Kasp\u0159\u00edkov\u00e1 N, et al. Neutrophil-to-lymphocyte count ratio as a biomarker of bacterial infections. Open Medicine 2012; 7(2):258\u201361.","DOI":"10.2478\/s11536-012-0002-3"},{"key":"146769_B46","doi-asserted-by":"crossref","unstructured":"46. G\u00fcrol G, \u00c7iftci \u0130H, Terizi HA, et al. Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis? J Microbiol Biotechnol 2015; 25(4):521\u20135.","DOI":"10.4014\/jmb.1408.08060"},{"key":"146769_B47","doi-asserted-by":"crossref","unstructured":"47. Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol 2004; 57(9):950\u20135.","DOI":"10.1136\/jcp.2004.017335"},{"key":"146769_B48","doi-asserted-by":"crossref","unstructured":"48. Holub M, Kluckov\u00e1 Z, Beneda B, et al. Changes in lymphocyte subpopulations and CD3+\/DR+ expression in sepsis. Clin Microbiol Infect 2000; 6(12):657\u201360.","DOI":"10.1046\/j.1469-0691.2000.00175.x"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/146769\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/146769\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=146769&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:29:15Z","timestamp":1748870955000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/146769\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.67.e146769","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"type":"electronic","value":"1314-2143"},{"type":"print","value":"0204-8043"}],"subject":[],"published":{"date-parts":[[2025,6,2]]},"article-number":"e146769"}}